Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: postpartum hemorrhage major surgical or invasive procedure: (1) blood product recussitation (2) uterotonic administration with pelvic exam under anesthesia (3) interventional radiological embolization of the right uterine artery with temporary gelfoam and the left uterine artery with permanent partially occlusive platinum coils history of present illness: 21 yo g1p1 pod# 15 s/p c/s on and pod #3 s/p d&c on was discharged home today. pt started to have increased vaginal bleeding at 4pm, saturating approximately 17 pads. on arrival to l&d, pt had lost approximately 500 cc blood during the exam. pt denies chest pain, shortness of breath. pt feels dizzy, lightheaded and she has uterine tenderness. past medical history: pobhx: primary ltcs secondary to arrest of descent. pgynhx: none pmh: none psh: ltcs , d&c social history: no t/e/d family history: non-contributory physical exam: 98.7, 99-120, 113/68, 20, 100% ra anxious, tearful lungs clear to auscultation bilaterally tachycardic. no murmurs, rubs, gallops abd soft, nondistended. firm fundus 3 fingerbreadths below umbilicus. tender to palpation. ext: no le edema, nontender gu: saturating peripads, pelvic deferred until or pertinent results: 11:20pm type-art po2-219* pco2-24* ph-7.44 total co2-17* base xs--5 intubated-intubated vent-controlled 11:20pm lactate-3.5* na+-139 k+-3.2* cl--115* 11:20pm hgb-13.5 calchct-41 11:20pm freeca-1.00* 11:04pm wbc-13.1* rbc-4.37# hgb-12.8# hct-36.0# mcv-82 mch-29.3 mchc-35.5* rdw-16.7* 11:04pm plt count-120* 11:04pm pt-13.7* ptt-36.8* inr(pt)-1.2 11:04pm fibrinoge-149*# 08:56pm glucose-102 urea n-10 creat-0.7 sodium-143 potassium-3.6 chloride-109* total co2-23 anion gap-15 08:56pm alt(sgpt)-13 ast(sgot)-14 08:56pm uric acid-5.9* 08:56pm wbc-9.6 rbc-3.03* hgb-8.8* hct-25.4* mcv-84 mch-29.1 mchc-34.7 rdw-15.1 08:56pm plt count-235 08:56pm pt-12.3 ptt-28.1 inr(pt)-1.0 08:56pm fibrinoge-310 10:35pm wbc-10.2 rbc-3.21* hgb-9.5*# hct-26.8* mcv-84 mch-29.5 mchc-35.3* rdw-15.4 10:35pm plt count-163 10:35am genta-0.3* 03:30am genta-2.5* brief hospital course: pt was admitted for vaginal bleeding, received hemabate, pitocin, and a transfusion was started prior to the patient going to the operating room. in the or, the patient received 6u prbcs, had a pelvic exam under anesthesia, vaginal packing, and a central line and arterial line placed. pt continued to have vaginal bleeding and it was decided to pursue uterine artery embolization to control the bleeding on . a right uterine artery pseudoaneurysm was embolized with gelfoam and the left uterine artery had a distal partial coil placed. pt received an additional 3u prbcs in the or. pt was started on empiric zosyn and flagyl for chronic endometritis following the procedure and was transferred to the icu intubated. serial hematocrits were followed and vaginal bleeding decreased. id was consulted and pt was continued on zosyn, but changed to doxycycline. pt was transferred to the floor from the icu on . on the floor, the patient's hematocrit and bleeding were stable. the patient did not develop signs or symptoms of blood loss anemia. the patient did not have further vaginal bleeding until when passed a large clot. pt was started on pitocin, methergine x 24 hours, and levo/flagyl at this time. pt did not have further episodes of vaginal bleeding or passing of large clots. hematology was consulted and it was thought that the delayed postpartum hemorrhage was likely due to local anatomic and mechanical factos as she has no personal history of bleeding. given the fact that she had received such a high volume of blood products during a complete evluation was deferred until patient is an outpatient. hospital course was further complicated by diarrhea which was thought to be seondary to uterotonics. c diff was negative. overall, postpartum hemorrhage thought to be secondary to subinvolution of the placental site vs abnormal vessel in the lower uterine segment vs. retained pocs. medications on admission: percocet motrin discharge medications: 1. levofloxacin 500 mg tablet sig: one (1) tablet po once a day for 8 days days: take one tablet of levofloxacin daily to complete a 14 day course on . disp:*8 tablet(s)* refills:*0* 2. flagyl 500 mg tablet sig: one (1) tablet po twice a day for 8 days: take one tablet of flagyl in the morning and a second in the evening to complete a total of 14 days of flagyl therapy on . disp:*16 tablet(s)* refills:*0* 3. omeprazole 20 mg capsule, delayed release(e.c.) sig: one (1) capsule, delayed release(e.c.) po once a day for 14 days: take one tablet of omeprazole at bed time for your stomach for the next two weeks. disp:*14 capsule, delayed release(e.c.)(s)* refills:*0* discharge disposition: home discharge diagnosis: delayed post partum hemorrhage transfusion of packed red blood cells and ffp: in total for the delivery experience, patient received 15 units of packed red blood cells and 4 units of ffp. discharge condition: as of wednesday : uterine bleeding seems to have stopped, uterus is 2-3 cm below umbilicus, and patient continues on empiric antibiotic coverage with levofloxacin 500 mg po q d + flagyl 500 mg po bid which are scheduled to continue x 14 days until discharge instructions: if bleeding starts again, call "911". if fever, go to hospital. if all well, come to on monday for check-up continue on levoquin 500mg daily and flagyl 500mg three times a day through . followup instructions: monday or also will need follow up with hematology in 3 weeks md, procedure: continuous invasive mechanical ventilation for less than 96 consecutive hours venous catheterization, not elsewhere classified insertion of endotracheal tube arterial catheterization other endovascular procedures on other vessels transfusion of packed cells diagnoses: thrombocytopenia, unspecified anemia, unspecified anemia of mother, postpartum condition or complication delayed and secondary postpartum hemorrhage, postpartum condition or complication major puerperal infection, postpartum condition or complication laceration of cervix, postpartum condition or complication chronic inflammatory diseases of uterus, except cervix congenital abnormalities of uterus, postpartum condition or complication aneurysm of other specified artery postpartum coagulation defects, postpartum condition or complication 

Answer: The patient is high likely exposed to